ArticleBioengineered2022

The anti-fibrotic agent nintedanib protects chondrocytes against tumor necrosis factor-ɑ (TNF-ɑ)-induced extracellular matrix degradation.

Chuankun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.